lilly retatrutide trial New Phase 3 data just dropped π Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Eli Lilly Reports Strong Late-Stage
Description
How are stability studies conducted for GLP-1 peptides
"Consistent purity batch after batch
McCarty, a gastroenterologist and researcher at Houston Methodist who led the study
A systematic review of 14 studies suggests that that fasting and postprandial lipopolysaccharide (LPS) are increased in patients with diabetes (153)
